Skip to main content

Facing criticism over insulin prices, drugmakers offer more affordable options

Eli Lilly and Novo Nordisk are separately offering help to people who are struggling to pay for their insulin, in a move that underscores how differently drugmakers are approaching the highly politicized topic of insulin prices.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.